Literature DB >> 6973414

The schistosomiasis problem in the world: results of a WHO questionnaire survey.

L S Iarotski, A Davis.   

Abstract

This article presents an overview of the magnitude of the schistosomiasis problem throughout the world, and is based on information on schistosomiasis control programmes provided by 103 countries in reply to a questionnaire circulated by the World Health Organization in 1976. According to the data either given in these replies, published, or provided in internal reports to WHO, schistosomiasis is one of the most widespread parasitic infections of man. Some 500 million people are thought to be exposed to infection and four main species of schistosomes are prevalent, together with their various intermediate snail hosts, in 73 countries. Control programmes are operating in 41% of responding endemic countries although they are on a national scale only in Brazil, Dominican Republic, Egypt, Iran, Iraq, Japan, Morocco, Puerto Rico, St Lucia, Tunisia, and Venezuela. It appears that a maximum of only 1-2% of all cases have been treated, the most frequently used drugs being niridazole and hycanthone. A small number of efficient molluscicides are in regular use but their high cost precludes large-scale application. Installation of water supplies and health education are the most frequently used non-specific control measures. Nearly 50% of endemic countries use more than three different methods of control simultaneously. The national schistosomiasis control programmes in Brazil, Egypt, Iran, Japan, Puerto Rico, and Venezuela are examples of combined approaches that have resulted in a significant decline in the prevalence of schistosomiasis. Finally, some specific needs in research, control, and training of personnel are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973414      PMCID: PMC2396036     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  12 in total

1.  Review of prevalence and distribution of schistosomiasis in Japan.

Authors:  M Yokogawa
Journal:  Southeast Asian J Trop Med Public Health       Date:  1976-06       Impact factor: 0.267

2.  Multicentre trials of praziquantel in human schistosomiasis: design and techniques.

Authors:  A Davis; D H Wegner
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

3.  A consideration of economic impact of schistosomiasis.

Authors:  W H Wright
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

4.  Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections.

Authors:  T Ishizaki; E Kamo; K Boehme
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

5.  Current chemotherapy of schistosomiasis in Japan.

Authors:  M Yokogawa
Journal:  Southeast Asian J Trop Med Public Health       Date:  1976-06       Impact factor: 0.267

6.  The use of a molluscicide in conjunction with chemotherapy to control Schistosoma haematobium at the Barombi Lake foci in Cameroon. III. Conclusions and costs.

Authors:  B O Duke; P J Moore
Journal:  Tropenmed Parasitol       Date:  1976-12

7.  Schistosomiasis control in Puerto Rico: twenty-five years of operational experience.

Authors:  H Negrón-Aponte; W R Jobin
Journal:  Am J Trop Med Hyg       Date:  1979-05       Impact factor: 2.345

8.  Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium.

Authors:  A Davis; J E Biles; A M Ulrich
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

9.  Preliminary trials with praziquantel in human infections due to Schistosoma mansoni.

Authors:  N Katz; R S Rocha; A Chaves
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

10.  Control of schistosomiasis in Guayama and Arroyo, Puerto Rico.

Authors:  W R Jobin; F F Ferguson; J R Palmer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

View more
  13 in total

1.  Human immune responses to Schistosoma mansoni vaccine candidate antigens.

Authors:  A Ribeiro de Jesus; I Araújo; O Bacellar; A Magalhães; E Pearce; D Harn; M Strand; E M Carvalho
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Succinate cytochrome c reductase in schistosomiasis: in vitro inhibition by some schistosomicidal drugs.

Authors:  Mahmoud Balbaa; Nihad M Abdel Moneam; Mohamed El-Kersh; Heba Omran; Kamal Kandeel
Journal:  J Physiol Biochem       Date:  2010-08-03       Impact factor: 4.158

3.  A simplified dosage schedule of metrifonate in the treatment of Schistosoma haematobium infection in Somalia.

Authors:  Y Aden-Abdi; L L Gustafsson; S A Elmi
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 4.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

5.  The unacknowledged impact of urinary schistosomiasis in children: 5 cases from Kumasi, Ghana.

Authors:  S Antwi; K E K Aboah; C K G Sarpong
Journal:  Ghana Med J       Date:  2014-12

Review 6.  Schistosomiasis in childhood.

Authors:  E Doehring
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

7.  Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.

Authors:  Amélia Ribeiro de Jesus; Andréa Magalhães; Delfin Gonzalez Miranda; Roberval Gonzalez Miranda; Maria Ilma Araújo; Adriana Almeida de Jesus; Angela Silva; Luciana B Santana; Edward Pearce; Edgar M Carvalho
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 8.  Bladder cancer: approaches to prevention and control.

Authors:  V Koroltchouk; K Stanley; J Stjernswärd; K Mott
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

9.  The global status of schistosomiasis and its control.

Authors:  L Chitsulo; D Engels; A Montresor; L Savioli
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

10.  Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection.

Authors:  Robson Da Paixão De Souza; Luciana Santos Cardoso; Giuseppe Tittoni Varela Lopes; Maria Cecília F Almeida; Ricardo Riccio Oliveira; Leda Maria Alcântara; Edgar M Carvalho; Maria Ilma Araujo
Journal:  J Parasitol Res       Date:  2012-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.